Compass Therapeutics, Inc. short interest in 2025
In 2025, Compass Therapeutics, Inc.'s disclosed short interest ran from 2.32% of shares outstanding on 15 Jan 2025 to 12.14% on 31 Dec 2025, a change of +9.82 percentage points. The year's high was 12.14% on 31 Dec 2025 and its low 2.00% on 31 Jan 2025, averaging 6.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.63 days on 30 May 2025. Full history: Compass Therapeutics, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 2.32% (15 Jan 2025)
- End of year
- 12.14% (31 Dec 2025)
- Change
- +9.82 pp
- High
- 12.14% (31 Dec 2025)
- Low
- 2.00% (31 Jan 2025)
- Average
- 6.57%
- Highest days to cover
- 13.63 (30 May 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 2.32% | 1.00 | results (8-K) |
| 31 Jan 2025 | 2.00% | 1.54 | |
| 14 Feb 2025 | 2.57% | 3.16 | |
| 28 Feb 2025 | 2.69% | 4.01 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 3.35% | 5.86 | |
| 31 Mar 2025 | 4.81% | 6.81 | |
| 15 Apr 2025 | 5.94% | 1.97 | |
| 30 Apr 2025 | 5.52% | 10.70 | |
| 15 May 2025 | 5.00% | 6.91 | 10-Q filed, results (8-K) |
| 30 May 2025 | 5.37% | 13.63 | |
| 13 Jun 2025 | 5.34% | 7.62 | |
| 30 Jun 2025 | 5.35% | 7.78 | |
| 15 Jul 2025 | 5.67% | 10.42 | |
| 31 Jul 2025 | 5.86% | 11.05 | |
| 15 Aug 2025 | 6.89% | 5.36 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 7.41% | 10.02 | |
| 15 Sep 2025 | 8.78% | 13.24 | |
| 30 Sep 2025 | 10.71% | 8.13 | |
| 15 Oct 2025 | 11.11% | 8.65 | |
| 31 Oct 2025 | 9.39% | 9.26 | |
| 14 Nov 2025 | 9.34% | 7.73 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 9.79% | 8.30 | |
| 15 Dec 2025 | 10.40% | 11.08 | |
| 31 Dec 2025 | 12.14% | 10.73 |
See also: Compass Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.